{
  "id": "CD013474.PUB2",
  "draft": "What are the benefits and harms of maintenance therapy (treatment to prevent cancer from coming back) for people with chronic lymphocytic leukaemia (a type of blood cancer)?\n\n- For people with chronic lymphocytic leukaemia, maintenance therapy may stop the cancer from getting worse for a longer time (progression-free survival). However, we are not sure if it helps people live longer overall, and it may cause more serious side effects.\n- Different types of maintenance therapy, such as anti-CD20 monoclonal antibodies (a type of protein that attaches to specific cells, including cancer cells) and immunomodulatory drugs (medicines that modify the immune system), have varying benefits and harms. For instance, both improved progression-free survival but also increased side effects. More research is needed to fully understand their long-term effects.\n- Future studies should investigate the effects of maintenance therapy on health-related quality of life (how well or poorly people feel and function in their daily lives), and compare the benefits and harms of different maintenance therapies, to help people with chronic lymphocytic leukaemia and their healthcare providers make informed decisions about treatment.\n\nWhat is chronic lymphocytic leukaemia and why is it a problem?\nChronic lymphocytic leukaemia (CLL) is a type of cancer that affects the blood and bone marrow. It is the most common type of leukaemia in adults and is currently incurable. CLL can cause a range of problems, including an increased risk of infections, anaemia (a condition where the body has a lower than normal number of red blood cells), and bleeding. Treatment for CLL usually involves chemotherapy (using drugs to kill cancer cells), targeted therapy (using drugs that specifically target cancer cells), or a combination of both. However, as the disease progresses, the treatment becomes less effective, and the risk of complications increases. We need new and effective treatments to manage CLL.\n\nWhat are the current treatment options for chronic lymphocytic leukaemia?\nThe current treatment options for CLL include chemotherapy, targeted therapy, and immunotherapy (using the body's immune system to fight cancer). Maintenance therapy is another approach that involves giving treatment to prevent the disease from coming back after it has been controlled. This can include drugs such as monoclonal antibodies, immunomodulatory agents, and targeted therapies.\n\nWhat did the review authors want to find out?\nThe review authors wanted to find out the effects and safety of maintenance therapy for people with CLL. They looked at different types of maintenance therapy, including anti-CD20 monoclonal antibodies, immunomodulatory drugs, and targeted therapies. They wanted to know whether these treatments can improve survival, reduce the risk of the disease coming back, and improve quality of life. They also wanted to know about the potential harms of these treatments, such as side effects and increased risk of infections.\n\nHow did we do the review?\nWe searched for studies comparing maintenance therapies for chronic lymphocytic leukaemia, summarized their results, and rated our confidence in the evidence to assess the effects and safety of these treatments.\n\nWhat did we find?\nWe found 11 studies that involved 2393 people with chronic lymphocytic leukaemia. The median age of participants was 54.1 to 71.7 years, and 59.5% were males. The studies compared different maintenance therapies, including anti-CD20 monoclonal antibodies, immunomodulatory drugs, and anti-CD52 monoclonal antibodies, with placebo (a dummy treatment) or observation (watching the patients without giving them any treatment). In these studies, researchers followed people for a typical period of 12 to 73 months to see what happened to them. We did not find any studies on novel small molecular inhibitors. Maintenance therapy for chronic lymphocytic leukaemia probably improves progression-free survival, but may increase adverse events. It is unclear if maintenance therapy has an effect on overall survival. For people with CLL, maintenance therapy may reduce the risk of disease progression, but may also cause more unwanted effects.\n\nWhat are the limitations of the evidence?\nThe evidence is limited because the studies were very small, participants may have known which treatment they received, and not all studies reported data on all outcomes of interest.\n\nHow up to date is this review?\nThe evidence is up to date to January 2022.",
  "metrics": [
    {
      "linguistic_evaluation": {
        "words": {
          "value": 712,
          "rating": "within_limit",
          "direction": null,
          "feedback": null
        },
        "sentences": {
          "value": 37,
          "rating": "info",
          "direction": null,
          "feedback": null
        },
        "words_per_sentence": {
          "value": 19.243243243243242,
          "rating": "P25",
          "direction": "lower_better",
          "feedback": null
        },
        "passive_voice": {
          "value": 10,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "active_voice": {
          "value": 79,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "pronouns": {
          "value": 40,
          "rating": "P75",
          "direction": "higher_better",
          "feedback": null
        },
        "nominalization": {
          "value": 33,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 33.0 to <13.0 (median)"
        },
        "nouns": {
          "value": 218,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 218.0 to <116.0 (median)"
        },
        "flesch_reading_ease": {
          "value": 43.411815973276674,
          "rating": "P50",
          "direction": "higher_better",
          "feedback": null
        },
        "flesch_kincaid_grade": {
          "value": 11.984808685089583,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "automated_readability_index": {
          "value": 12.409753644093534,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "coleman_liau_index": {
          "value": 12.895898876404491,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "gunning_fog_index": {
          "value": 16.62988156696022,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "lix": {
          "value": 52.529760097175824,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "rix": {
          "value": 6.405405405405405,
          "rating": "P50",
          "direction": "lower_better",
          "feedback": null
        },
        "smog_index": {
          "value": 15.68857754044952,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 15.7 to <12.1 (median)"
        },
        "dale_chall_readability": {
          "value": 8.028917112055877,
          "rating": "P75",
          "direction": "lower_better",
          "feedback": null
        },
        "complex_words_dc": {
          "value": 319,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 319.0 to <160.0 (median)"
        },
        "complex_words": {
          "value": 159,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 159.0 to <84.0 (median)"
        },
        "long_words": {
          "value": 237,
          "rating": "BEYOND_P90",
          "direction": "lower_better",
          "feedback": "Deviates from typical PLS patterns. Consider reducing from 237.0 to <122.0 (median)"
        }
      },
      "word_count_status": {
        "word_count": 712,
        "limit": 850,
        "status": "within_limit",
        "message": "Word count: 712 ✓ WITHIN LIMIT (≤850 words)"
      },
      "summary": {
        "P25_count": 1,
        "P50_count": 7,
        "P75_count": 4,
        "P90_count": 0,
        "P10_count": 0,
        "BEYOND_P90_count": 6,
        "BELOW_P10_count": 0,
        "total_evaluated": 18,
        "P25_percentage": 5.555555555555555,
        "P50_percentage": 38.88888888888889,
        "P75_percentage": 22.22222222222222,
        "P90_percentage": 0,
        "P10_percentage": 0,
        "BEYOND_P90_percentage": 33.33333333333333,
        "BELOW_P10_percentage": 0,
        "best_quartile_rate": 27.77777777777778,
        "overall_assessment": "MODERATE CONFORMITY WITH PLS PATTERNS"
      }
    }
  ],
  "evaluation": [
    {
      "grade": "NOT_APPROVED",
      "feedback": "This is a solid draft that passes all critical checks for accuracy and completeness. However, it needs revision to improve clarity for a lay audience. The main issue is the use of complex medical terms and dense, noun-heavy sentences that make the text difficult to read, even with definitions provided. Addressing the 3 improvements below will make the summary much more accessible for patients and their families.\n\nHere are the top 3 areas for improvement:\n\n1.  **Replace complex medical terms with simpler, everyday language.** The summary relies on technical terms like 'progression-free survival' and 'adverse events'. While these are sometimes defined, using simpler phrases consistently makes the text much easier to follow.\n    *   **Problematic sentence:** \"Maintenance therapy for chronic lymphocytic leukaemia probably improves progression-free survival, but may increase adverse events.\"\n    *   **Why it's a problem:** A reader has to remember the definition of 'progression-free survival' from earlier. 'Adverse events' is medical jargon.\n    *   **Suggested rewrite:** \"Maintenance therapy for this type of leukaemia probably stops the cancer from getting worse for longer, but it may also cause more unwanted effects.\"\n\n2.  **Simplify noun-heavy sentences by using more active verbs.** Several sentences are built around complex nouns ('treatment', 'combination', 'investigation') instead of direct verbs. This makes the text feel dense and academic.\n    *   **Problematic sentence:** \"Treatment for CLL usually involves chemotherapy (using drugs to kill cancer cells), targeted therapy (using drugs that specifically target cancer cells), or a combination of both.\"\n    *   **Why it's a problem:** This sentence is passive and noun-focused. Rewriting with active verbs makes it more direct and easier to understand.\n    *   **Suggested rewrite:** \"To treat CLL, doctors usually use chemotherapy (drugs that kill cancer cells), targeted therapy (drugs that attack specific cancer cells), or combine both treatments.\"\n\n3.  **Clarify the key message about benefits and harms.** The second key message could be more direct in stating the main trade-off for patients.\n    *   **Problematic sentence:** \"Different types of maintenance therapy, such as anti-CD20 monoclonal antibodies... and immunomodulatory drugs..., have varying benefits and harms. For instance, both improved progression-free survival but also increased side effects.\"\n    *   **Why it's a problem:** This is a bit wordy and buries the main point. Focusing on the core trade-off (more time without the cancer getting worse vs. more side effects) is clearer.\n    *   **Suggested rewrite:** \"Different types of maintenance therapy had similar results: they helped stop the cancer from getting worse for a longer time, but they also caused more side effects.\"\n",
      "pls_evaluation_summary": "The linguistic analysis shows moderate conformity with typical PLS patterns. While sentence length and use of pronouns are good, there are significant deviations in vocabulary complexity. Six key metrics are in the 'BEYOND_P90' range, indicating the text is much harder to read than a typical PLS. The high scores for 'smog_index' (15.7), 'complex_words' (159), 'nominalization' (33), and 'nouns' (218) strongly suggest that the vocabulary is too technical and the sentences are too dense for a lay audience."
    }
  ]
}